"MIATA"-Minimal Information about T Cell Assays Journal Article
| Authors: | Janetzki, S.; Britten, C. M.; Kalos, M.; Levitsky, H. I.; Maecker, H. T.; Melief, C. J. M.; Old, L. J.; Romero, P.; Hoos, A.; Davis, M. M. |
| Article Title: | "MIATA"-Minimal Information about T Cell Assays |
| Abstract: | Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem. © 2009 Elsevier Inc. All rights reserved. |
| Keywords: | treatment response; letter; neoplasms; t lymphocyte; t-lymphocytes; biological marker; quality control; patient monitoring; practice guideline; prediction; immune response; immunotherapy; cancer vaccines; vaccination; practice guidelines as topic; reliability; immunoassay; immunological monitoring; enzyme linked immunospot assay; immunosurveillance; good laboratory practice; monitoring, immunologic; viral vaccines; virus diseases |
| Journal Title: | Immunity |
| Volume: | 31 |
| Issue: | 4 |
| ISSN: | 1074-7613 |
| Publisher: | Cell Press |
| Date Published: | 2009-10-16 |
| Start Page: | 527 |
| End Page: | 528 |
| Language: | English |
| DOI: | 10.1016/j.immuni.2009.09.007 |
| PUBMED: | 19833080 |
| PROVIDER: | scopus |
| PMCID: | PMC3762500 |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 15" - "Export Date: 30 November 2010" - "CODEN: IUNIE" - "Source: Scopus" |
